UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

Cancer chemotherapy and pharmacology, 2011-09, Vol.68 (3), p.593-601

2011

Volltextzugriff (PDF)

Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs

Toxicology (Amsterdam), 2011-11, Vol.289 (2), p.141-150

2011

Volltextzugriff (PDF)

Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs

Current pharmaceutical biotechnology, 2013-03, Vol.14 (4), p.464-469

2013

Volltextzugriff (PDF)

Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols

Molecular cancer therapeutics, 2007-07, Vol.6 (7), p.2022-2028

2007

Volltextzugriff (PDF)

Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms

Journal of pharmacy and pharmacology, 2006-04, Vol.58 (4), p.469-479

2006

Volltextzugriff (PDF)

Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone

Cancer chemotherapy and pharmacology, 2006-01, Vol.57 (1), p.1-6

2006

Volltextzugriff (PDF)

Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography–tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-12, Vol.829 (1), p.123-135

2005

Volltextzugriff (PDF)

Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC–MS/MS and their pharmacokinetics in dogs

Journal of pharmaceutical and biomedical analysis, 2012-02, Vol.59, p.201-208

2012

Volltextzugriff (PDF)

Comment on 'Resveratrol in human cancer chemoprevention- choosing the 'right' dose'

Molecular nutrition & food research, 2012-04, Vol.56 (4), p.523-523

Kapetanovic, Izet M

2012

Volltextzugriff (PDF)

In vitro metabolic characterization, phenotyping, and kinetic studies of 9cUAB30, a retinoid X receptor-specific retinoid

Drug metabolism and disposition, 2007-07, Vol.35 (7), p.1157-1164

2007

Volltextzugriff (PDF)

Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone

Drug metabolism and disposition, 2009-05, Vol.37 (5), p.1089-1097

2009

Volltextzugriff (PDF)

Rapid access to preventive intervention development program in the Division of Cancer Prevention of the U.S. National Cancer Institute: an overview

Cancer epidemiology, biomarkers & prevention, 2009-03, Vol.18 (3), p.698-700

Kapetanovic, Izet M

2009

Volltextzugriff (PDF)

Toxicogenomics and Metabolomics of Pentamethylchromanol (PMCol)-Induced Hepatotoxicity

Toxicological sciences, 2011-12, Vol.124 (2), p.487-501

2011

Volltextzugriff (PDF)

Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading

Journal of pharmaceutical sciences, 2012-10, Vol.101 (10), p.3877-3885

2012

Volltextzugriff (PDF)

Overview of Commonly Used Bioinformatics Methods and Their Applications

Annals of the New York Academy of Sciences, 2004-05, Vol.1020 (1), p.10-21

2004

Volltextzugriff (PDF)

Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen

Mutation research, 2012-07, Vol.746 (1), p.78-88

2012

Volltextzugriff (PDF)

Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs

Drug and chemical toxicology (New York, N.Y. 1978), 2013-07, Vol.36 (3), p.284-295

2013

Volltextzugriff (PDF)

Drug Discovery and Development: Present and Future

Kapetanovic, Izet M

2011

Volltextzugriff (PDF)

In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes

Chemico-biological interactions, 2009-05, Vol.179 (2), p.263-272

2009

Volltextzugriff (PDF)

Determination and stability of CP-31398 in plasma from experimental animals by LC-MS/MS

Journal of pharmaceutical and biomedical analysis, 2011-12, Vol.56 (4), p.809-814

2011

Volltextzugriff (PDF)

Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability

Chemico-biological interactions, 2012-04, Vol.197 (1), p.16-22

2012

Volltextzugriff (PDF)

Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.995-1006

2011

Volltextzugriff (PDF)

Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats

Chemico-biological interactions, 2009-05, Vol.179 (2), p.233-239

2009

Volltextzugriff (PDF)

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats

Cancer chemotherapy and pharmacology, 2012-05, Vol.69 (5), p.1301-1306

2012

Volltextzugriff (PDF)

Assessment of oral toxicity and safety of 9-cis-UAB30, a potential chemopreventive agent, in rat and dog studies

Drug and chemical toxicology (New York, N.Y. 1978), 2011-07, Vol.34 (3), p.300-310

2011

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs

Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs

Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols

Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms

Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone

Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography–tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent

Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC–MS/MS and their pharmacokinetics in dogs

Comment on 'Resveratrol in human cancer chemoprevention- choosing the 'right' dose'

In vitro metabolic characterization, phenotyping, and kinetic studies of 9cUAB30, a retinoid X receptor-specific retinoid

Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone

Rapid access to preventive intervention development program in the Division of Cancer Prevention of the U.S. National Cancer Institute: an overview

Toxicogenomics and Metabolomics of Pentamethylchromanol (PMCol)-Induced Hepatotoxicity

Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading

Overview of Commonly Used Bioinformatics Methods and Their Applications

Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen

Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs

Drug Discovery and Development: Present and Future

In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes

Determination and stability of CP-31398 in plasma from experimental animals by LC-MS/MS

Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability

Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent

Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats

Assessment of oral toxicity and safety of 9-cis-UAB30, a potential chemopreventive agent, in rat and dog studies

Suchergebnisse filtern